No Detail Found!

HER-2/NEU Oncogene Amplification by Fluorescence in Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer.

Author(s)
Fouzia Lateef Department of Histopathology, Dr. Ziauddin Hospital, Karachi, Pakistan
Saba Jamal Department of Histopathology, Dr. Ziauddin Hospital, Karachi, Pakistan
Surrayya Nasir Department of Histopathology, Dr. Ziauddin Hospital, Karachi, Pakistan
Abstract
Objective: To investigate the concordance and discordance between the test results of Her-2/neu by immunohistochemistry (IHC) and flourescence In Situ hybridization (FISH) in breast cancer cases. Study Design: Descriptive cross-sectional study. Place and Duration of Study: Department of Histopathology, Dr. Ziauddin Hospital, Karachi, from 2011 to 2016. Methodology: Forty-three specimens of invasive ductal carcinoma of breast were evaluated for grade and Her-2/neu status using IHC and FISH methods. Concordance and discordance between their results was determined. Results: There is 100% concordance between FISH and IHC in cases scoring 0, 1+ (negative) and 3+ (positive) immunostaining. Tumour cases scoring 2+ immunostaining showed amplification in 69.2% cases. All grade-I tumours were non-amplified on FISH, while most of the grade-III tumours showed Her-2/neu amplification on FISH. There is significant association of Her-2/neu IHC with tumour grade and FISH (p<0.05). A fairly high proportion i.e. 69.7% of cases showed Her-2/neu gene amplification. There was high concordance between Her-2/neu testing on IHC and FISH, (Kappa co-efficient 0.466, p <0.001). Conclusion: Her-2/neu amplification increases with increasing grade of breast cancer. A high proportion of Her-2/neu gene amplified cases indicates aggressive disease in that area and need for FISH testing on large scale, which is the gold standard for equivocal cases on immunohistochemistry.
Publication Details
Page(s) 581-585
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 8, Year: 2018

Request the full text from PASTIC

References
SuiW,OuM,ChenJ,WasY,PengH,QiM, 2009.Comparison of immunohistochemistry (IHC) and fluorescence In Situ hybridization (FISH) assessment for Her-2/neu status in breast cancer,World J Surg Oncol 7 83 -
NikhraP,PatelS,TaviadD,ChaudharyS., 2014.Study of ER (estrogen receptor), PR (progesterone receptor) & Her-2/Neu (human epidermal growth factor receptor) expression by immunohistochemistry in breast carcinoma,IJBAR 5 275 -8
KoseogluRD,MuslehiddinogluA,ErkorkmazU,CaferlerJS,DurerP,OzonYH, 2011.An analysis of Her-2/Neu gene status in invasive ductal carcinomas using immunohistochemistry and fluorescence In Situ hybridization,Turk J Med Sci 41 809 -19
FitzgibbonsPL,DillonDA,AlsabehR,BermanMA,HayesDF,HicksDG, 2014.Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast,Arch Pathol Lab Med 138 595 -601
VarshneyD,ZhouYY,GellerSA,AlsabehR, 2004.Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing hercep test and pathVysion FISH assay,Am J Clin Pathol 121 70 -7
GoudKI,DayakarS,VijayalaxmiK,BabuSJ,VijayAR, 2012.Evaluation of HER-2 /neu status in breast cancer specimens using immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH) assay,Indian J Med Res 135 312 -7
SaglicanY, 2015.Her-2/neustatus in breast cancer specimens: comparison of immunohistochemistry (IHC) and flourescence In Situ hybridization (FISH) Methods,Int J Morphol 33 737 -42
MoatterT,AbanM,IqbalW,AzamI,PervaizA,SiddiquiF, 2011.Status of HER-2/NEU amplification, polysomy17 and histopathological features of 425 Pakistani breast cancer patients,Asian Pac J Cancer Prev 12 3069 -73
NassarA,KhoorA,RadhakrishananR,RadhakrishnanA,CohenC, 2014.Correlation of Her-2/neu overexpression with gene amplification and its relation to chromosome 17 aneuploidy: A 5-year experience with invasive ductal and lobular carcinomas,Int J Clin Exp Pathol 7 6254 -61
MostafaNA,EissaSS,BelalDM,ShomanSH, 2011.Assessment of Her-2/Neu gene amplification status in breast carcinoma with equivocal 2+ Her-2/Neu immunostaining,J Egypt Natl Canc Inst 23 41 -6
Ivkovic-KapiclT,Knezevic-UsajS,Djilas-IvanovicD,PanjkovicM., 2007.Correlation of Her-2/Neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer,Anticancer Res 21 673 -8
KuoSJ,WangBB,ChangCS,ChenTH,YehKT,LeeDJ, 2007.Comparison of immunohistochemical and flourescence In Situ hybridization assessment for HER-2/NEU status In Taiwanese breast cancer patients,Taiwan J Obstet Gynecol 46 146 -51
MurthySS,SandhyaDG,AhmedF,GoudKI,DaynalM,SuseelaK, 2011.Assessment of Her-2/neu status by fluorescence In Situ hybridization in immunohistochemistryequivocal cases of invasive ductal carcinoma and aberrant signal patterns. A study at a tertiary cancer center,Indian J Pathol Microbiol 54 532 -38
GhaffariSR,SabokbarT,DastanJ,RafatiM,Moossavi S, 2011.Her-2/neu amplification status in Iranian breast cancer pateitns: comparison of immunohistochemistry (IHC) and flourescence In Situ hybridization (FISH),Asian Pac J Cancer Prev 12 1031 -4
VargaZ,NoskeA,RamachC,PadbergB,Moch H, 2013.Assessment of Her-2/neu status in breast cancer: Overall positivity rate and accuracy by flourscence In Situ hybridization and Immunohistochemistry in a single institution over 12 years: a quality control study,Bio Med Central 30 13 -615
SarodeVR,XianQD,ChristieA,CollinsR,RaoR,LeitchAM, 2015.Evaluation of Her-2/neu by immunohistochemistry using computer based image analysis and correlation with gene amplification by fLourescence In Situ hybridization assay: A 10 years experience and impact of test standardization on concordance rate,Arch Pathol Lab Med 139 922 -8
PanjwaniP,EpariS,KarpateA,ShirsatH,RajsekharanP,BasakR, 2010.Assessment of HER-2/neu status in breast cancer using fluorescence In Situ hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre in India,Indian J Med Res 287 -94
SinghaiR,PatilV,PatilA,Immunohistochemical (IHC), 2011.HER2/Neu and flourescentIn Situ hybridization (FISH) gene amplification of breast cancer in Indian women,Asian Pac J Cancer Prev 12 179 -83
AL KhattabiH,KelanyA,BuhmeidaA,Al MaghrabiJ,LariS,ChaudharyA, 2010.Evaluation of HER-2/Neu gene amplification by flourescence In Situ hybridization and immunohistochemistry in Saudi female breast cancer,Anticancer Res 30 4081 -8
PayandehM,SadeghiE,KoohianAK, 2014.Comparison of IHC, FISH, ER and PR in breast cancer in Western Iran,Am J Prev Med 2 37 -41
Garcia-CaballeroT,MenendezMD,Vazquez-BoqueteA,GallegoR,FortezaJ,FragaM., 2006.HER-2 status determination in breast carcinomas. A practical approach,Histol Histopathol 21 227 -36
GrimmEE,SchmidtRA,SwansonPE,DintzisSM,AllisonKH, 2010.Achieving 95% cross-methodological concordance in Her2/neu Testing,Am J Clin Pathol 134 284 -92
EswaracharyV,MohammedIG,JayannaPK,PatilOkalyGV,NargundAR,DhondalayGK, 2017.Her-2/neu testing in 432 consecutive breast cancer cases using FISH and IHC-A comparative study,JDCR 11 EC01 -5
PalaEE,ZekiogluO,ÖzdemirN,YilmazR,KapkacM., 2010.Comparison of immunohistochemistry and fluorescence In Situ hybridization for the analysis of Her-2/neu and iopoisomerase II-alpha status in human breast cancer,Turk J Pathol 26 222 -9
0

Citations

0

Downloads

81

Views